| 词条 | Prognosis marker |
| 释义 |
}} Prognostic markers are biomarkers used to measure the progress of a disease in the patient sample.[1] Prognostic markers are useful to stratify the patients into groups, guiding towards precise medicine discovery. The widely used prognostic markers in cancers include stage, size, grade, node and metastasis. In addition to these common markers, there are prognostic markers specific to different cancer types. For example estrogen level, progesterone and HER2 are markers specific to breast cancer patients. There is evidence showing that genes behaving as tumor suppressors or carcinogens could act as prognostic markers due to altered gene expression or mutation. Besides genetic biomarkers, there are also biomarkers that are detected in plasma or body fluid which can be metabolic or protein biomarkers. References1. ^{{cite web|url=http://medical-dictionary.thefreedictionary.com/prognostic+factor|title=Prognostic factor|website=Medical-dictionary.thefreedictionary.com|accessdate=10 July 2018}} {{oncology-stub}} 1 : Cancer staging |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。